regorafenib

Bayer’s regorafenib kicks off brain cancer platform trial
Bayer’s regorafenib kicks off brain cancer platform trial
Pharmaforum
Bayer
brain cancer
clinical trials
GBM
regorafenib
Flag link:
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
CP Wire
Bayer
regorafenib
glioblastoma
Flag link:
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer
regorafenib
glioblastoma
Flag link:
Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment
Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment
Bloomberg
colorectal cancer
Bayer
ONYX Pharmaceuticals
FDA
regorafenib
Flag link:
Priority Review for Bayer/Onyx
Priority Review for Bayer/Onyx
Yahoo/Zacks
Bayer
ONYX Pharmaceuticals
regorafenib
colorectal cancer
Flag link:
[video] Onyx Pharma CEO on New Cancer Drug
[video] Onyx Pharma CEO on New Cancer Drug
CNBC
ONYX Pharmaceuticals
Anthony Coles
Bayer
regorafenib
gastrointestinal cancer
Flag link:
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Flag link:
Top 10 late-stage cancer drugs in 2012
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Flag link:
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Yahoo/Fly on the Wall
ONYX Pharmaceuticals
regorafenib
GIST
Bayer
Flag link:
Bayer Says Drug Held Off Gastrointestinal Tumors in Study
Bayer Says Drug Held Off Gastrointestinal Tumors in Study
Bloomberg
gastrointestinal cancer
Bayer
regorafenib
Flag link:
2 High-Flying Biotechs Face a New Hurdle
2 High-Flying Biotechs Face a New Hurdle
Motley Fool
Bayer
ONYX Pharmaceuticals
Aeterna Zentaris
regorafenib
Keryx
Flag link:
Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects
Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects
TheStreet.com
ONYX Pharmaceuticals
colon cancer
Bayer
regorafenib
Flag link:
Onyx put selling hinges on time decay
Onyx put selling hinges on time decay
Yahoo/optionMONSTER
ONYX Pharmaceuticals
regorafenib
Flag link:
Bayer predicts blockbuster success for four of its late-stage drugs
Bayer predicts blockbuster success for four of its late-stage drugs
Fierce Biotech
Bayer
Xarelto
VEGF Trap-Eye
regorafenib
Alpharadin
Flag link:
5 One-Drug Wonders Going for No. 2
5 One-Drug Wonders Going for No. 2
Motley Fool
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Flag link:
Bayer and new partner Onyx crow over PhIII regorafenib success
Bayer and new partner Onyx crow over PhIII regorafenib success
Fierce Biotech
regorafenib
ONYX Pharmaceuticals
Bayer
colon cancer
Flag link:
Onyx Pharmaceuticals extends oncology working relationship with Bayer
Onyx Pharmaceuticals extends oncology working relationship with Bayer
Yahoo/AP
Bayer
ONYX Pharmaceuticals
regorafenib
Flag link:
FDA grants faster review to Bayer's regorafenib
FDA grants faster review to Bayer's regorafenib
Yahoo/AP
Bayer
FDA
regorafenib
gastrointestinal cancer
Flag link:
Bayer Moves Late Stage Candidate
Bayer Moves Late Stage Candidate
Yahoo/Zacks.com
Bayer
ONYX Pharmaceuticals
regorafenib
Flag link:
Bayer/Onyx Cancer Drug: Possible Additional Indication Looks Promising
Bayer/Onyx Cancer Drug: Possible Additional Indication Looks Promising
Seeking Alpha
Bayer
ONYX Pharmaceuticals
regorafenib
Flag link:

Pages